cMet recombinant protein from ProteoGenix; catalogue PX-P5209; research use only.
Know who made it. See the evidence. Buy through one marketplace.
cMet recombinant protein is a type of transmembrane tyrosine kinase receptor that is expressed in a variety of tissues. It is composed of a single polypeptide chain of 766 amino acids and has an extracellular domain, a transmembrane domain, and an intracellular domain.
ActivitycMet recombinant protein is involved in cell signaling pathways that regulate cell proliferation, migration, and differentiation. It is involved in the regulation of cell growth, survival, and angiogenesis.
ApplicationcMet recombinant protein is used in research to study its role in cancer and other diseases. It is also used as an antibody-drug target for the development of novel therapeutic agents.
ProteoGenix catalogue number PX-P5209. For research use only.
Host: Mammalian cells; Expression system: Eukaryotic expression; Purity: >90% as determined by SDS-PAGE; Molecular weight: 54.45 kDa; Tag: C-terminal His Tag; Fragment: Glu25-Gly519; Buffer: PBS, pH7.5; Applications: ELISA, WB.
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
